Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
Clinical trial NCT04031833 · COMPLETED
Trial details
- NCT number
- NCT04031833
- Sponsor
- Matinas BioPharma Nanotechnologies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2022-11-14
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.